11-12 September 2018 //  Lancaster Royal Hotel, London


Matthew E. Colpoys, Jr

Matthew E. Colpoys, Jr

Chief Executive Officer, Tactiva Therapeutics, Inc

Mr. Colpoys is the co-founder and CEO of Tactiva Therapeutics, Inc.  Tactiva is an iommuno-oncology company focused on dual TCR therapy for the treatment of solid tumors.  With over 30 years experience in the bio-pharmaceutical industry he has built multiple organizations for the commercialization of new products.  Previous companies include Genentech, Pharmacia Upjohn, Neurex, Elan and Insmed.


2017 Speakers

"It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance."

Bertrand Alexandre, Director, Marketing Europe, Celyad